دورية أكاديمية

2398P Are fibroblast growth factor receptor 3 (FGFR3) alterations a possible predictive factor for platinum-based chemotherapy and immunotherapy in metastatic urothelial carcinoma (MUC)?

التفاصيل البيبلوغرافية
العنوان: 2398P Are fibroblast growth factor receptor 3 (FGFR3) alterations a possible predictive factor for platinum-based chemotherapy and immunotherapy in metastatic urothelial carcinoma (MUC)?
المؤلفون: Ferrer-Mileo, L., Rodriguez Hernandez, A., Aversa, C., Rodríguez-Carunchio, L., Ribera, I., Trias Puigsureda, I., Oliva, L., Jimenez Blasco, N., García-Esteve, S., Álvarez, M., Rabella, M., Mellado Gonzalez, B., Torras, O. Reig
المصدر: In Annals of Oncology October 2023 34 Supplement 2:S1220-S1221
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2023.09.1047